找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Obesity, Fatty Liver and Liver Cancer; Jun Yu Book 2018 Springer Nature Singapore Pte Ltd. 2018 non-alcoholic fatty liver disease (NAFLD).

[复制链接]
楼主: 悲伤我
发表于 2025-3-26 21:27:29 | 显示全部楼层
发表于 2025-3-27 05:03:50 | 显示全部楼层
NAFLD Related-HCC: The Relationship with Metabolic Disorders,elopment. We also discussed the prevention options of NAFLD-HCC in view of obesity and metabolic disorder. These studies have extended our knowledge on the complicated mechanism of NAFLD and HCC, and provided the prevention options of NAFLD-HCC in patients with obesity and metabolic diseases.
发表于 2025-3-27 06:19:56 | 显示全部楼层
发表于 2025-3-27 11:28:21 | 显示全部楼层
Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC,n the pathogenesis of NAFLD-HCC. On the basis of currently wealthy knowledge of DNA epigenetics, the rapidly growing field of RNA epigenetics will certainly drive forward a new avenue of research direction shedding light on the advancement of better diagnostics, prognostics and therapeutics in the coming era of precision medicine.
发表于 2025-3-27 14:01:51 | 显示全部楼层
发表于 2025-3-27 20:20:23 | 显示全部楼层
Introduction,nd more than a third of them are obese. In addition to the well-publicized association of obesity with type II diabetes and cardiovascular diseases, emerging evidence indicates that obesity represents a major risk factor for fatty liver diseases and fatty liver disease-associated hepatocellular carcinoma (HCC).
发表于 2025-3-28 00:23:14 | 显示全部楼层
Microbiota, Obesity and NAFLD, largely unknown, changes in intestinal inflammation, gut permeability, energy harvest, anaerobic fermentation and insulin resistance have been described. In this chapter, we review the relationship between the gut microbiota, obesity and NAFLD, and highlight potential ways to modify the gut microbiota to help managing NAFLD patients.
发表于 2025-3-28 03:55:53 | 显示全部楼层
Book 2018ors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery..
发表于 2025-3-28 08:03:20 | 显示全部楼层
发表于 2025-3-28 12:55:19 | 显示全部楼层
0065-2598 nt topics in the field all together under one umbrella.Provi.This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together u
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-12 03:20
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表